Understanding and Diagnosing Pseudoxanthoma Elasticum (PXE)
At a Glance
Pseudoxanthoma elasticum (PXE) is a rare genetic disorder caused by ABCC6 gene mutations, leading to calcium buildup in the skin, eyes, and blood vessels. It is diagnosed through clinical exams for skin and eye changes, genetic testing, and blood tests measuring PPi levels.
Pseudoxanthoma elasticum (PXE) is a rare, inherited metabolic disorder that causes minerals like calcium to build up in tissues where they don’t belong, such as the skin, eyes, and blood vessels [1][2]. While it may first appear as a skin condition, it is actually a systemic (body-wide) issue caused by a “shortage” in the blood of a specific molecule that normally prevents this mineral buildup [1].
The Biological “Shield” and Genetics
Your body naturally produces a substance called inorganic pyrophosphate (PPi), which acts like a chemical shield to prevent calcium and other minerals from sticking to your elastic fibers [1][3].
In people with PXE, a change (mutation) in the ABCC6 gene prevents the liver from maintaining normal levels of PPi in the bloodstream [3][4]. Without enough PPi, minerals begin to deposit into the elastic tissues of the body, a process called ectopic calcification [1].
Inheritance: PXE is an autosomal recessive condition [5]. This means you must inherit two mutated copies of the ABCC6 gene—one from each parent—to develop the disease. If you have it, your siblings may also have a 25% chance of inheriting it. Your children will likely only be carriers (unaffected) unless your partner also carries a mutation [5][1].
Confirming the Diagnosis: The REACT-PXE Checklist
The diagnosis of PXE has been updated by the REACT-PXE consensus to ensure accuracy by combining physical exams, lab work, and genetic data [6]. To confirm you have PXE, your medical team will typically look for a combination of the following:
- Clinical Evaluation: A specialist looks for characteristic skin bumps or specific eye changes like angioid streaks or peau d’orange (a dimpled texture like an orange peel) [6].
- Molecular Genetic Testing: Identifying two pathogenic (disease-causing) variants in the ABCC6 gene is the most definitive way to confirm the diagnosis [6].
- Skin Biopsy: If the diagnosis is unclear, a small sample of skin may be examined under a microscope to see if the elastic fibers are calcified [6].
- Plasma PPi Levels: A newer, highly accurate blood test can measure the level of PPi in your blood. Abnormally low levels are strongly suggestive of PXE [7].
Ruling Out the “Look-Alikes”
Because several other conditions can cause similar skin or vascular issues, doctors must carefully distinguish PXE from its “mimics” using genetic and blood tests [6]:
- PXE-PDE: This is often caused by aging or UV exposure rather than genetics. It shows a loss of elastic fibers rather than the calcification seen in true PXE, and it lacks the systemic heart and eye risks [8][9].
- GACI: A related genetic condition involving the ENPP1 or ABCC6 genes that requires different medical management [10].
- GGCX-Related Syndrome: Caused by the GGCX gene. It can look like PXE on the skin but also includes blood-clotting issues [11].
Testing your genes and PPi levels ensures you get the correct diagnosis and the most appropriate care plan [7][6]. For further information, visit How PXE Affects Your Body: Symptoms and Standard Treatments and Tracking PXE: The Phenodex Score, Care Team, and Emerging Research.
In this guide
2 chapters
How PXE Affects Your Body: Symptoms and Standard Treatments
Learn how Pseudoxanthoma elasticum (PXE) affects your skin, eyes, heart, and GI tract. Discover standard treatments, symptom management, and what to avoid.
Tracking PXE: The Phenodex Score, Care Team, and Emerging Research
Learn how the Phenodex score tracks Pseudoxanthoma Elasticum (PXE) progression. Understand your care team's role and discover emerging clinical trials.
Common questions in this guide
How is Pseudoxanthoma Elasticum (PXE) diagnosed?
What causes PXE?
Is Pseudoxanthoma Elasticum inherited?
Why do doctors test PPi levels for PXE?
What is the difference between PXE and PXE-PDE?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on the REACT-PXE consensus, which of my clinical findings most strongly suggest a PXE diagnosis?
- 2.What is my current plasma inorganic pyrophosphate (PPi) level, and how does it compare to the diagnostic threshold?
- 3.Should my siblings or children undergo ABCC6 genetic testing or PPi screening?
- 4.How do we distinguish my skin findings from PXE-PDE or other similar conditions?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (11)
- 1
ABCC6 and Pseudoxanthoma Elasticum: The Face of a Rare Disease from Genetics to Advocacy.
Moitra K, Garcia S, Jaldin M, et al.
International journal of molecular sciences 2017; (18(7)) doi:10.3390/ijms18071488.
PMID: 28696355 - 2
Threads of Elasticity: A Single Variant Journey Through Pseudoxanthoma Elasticum's Clinical Maze.
Nagarajan DR, Mani Jacob D, Kakade S
Cureus 2025; (17(8)):e89237 doi:10.7759/cureus.89237.
PMID: 40901220 - 3
Abcc6 Knockout Rat Model Highlights the Role of Liver in PPi Homeostasis in Pseudoxanthoma Elasticum.
Li Q, Kingman J, van de Wetering K, et al.
The Journal of investigative dermatology 2017; (137(5)):1025-1032 doi:10.1016/j.jid.2016.11.042.
PMID: 28111129 - 4
ABCC6, Pyrophosphate and Ectopic Calcification: Therapeutic Solutions.
Shimada BK, Pomozi V, Zoll J, et al.
International journal of molecular sciences 2021; (22(9)) doi:10.3390/ijms22094555.
PMID: 33925341 - 5
Cutaneous and oral manifestations of pseudoxanthoma elasticum: clinicopathological features of an uncommon disorder.
Teixeira LR, Chahud F, Simão JCL, et al.
Clinical and experimental dermatology 2021; (46(4)):745-748 doi:10.1111/ced.14549.
PMID: 33378100 - 6
REACT-PXE: a consensus on diagnosis and future research concerning pseudoxanthoma elasticum (PXE).
Martin L, Spiering W, Aelbrecht K, et al.
Annales de dermatologie et de venereologie 2026; (153(1)):103440 doi:10.1016/j.annder.2025.103440.
PMID: 41519013 - 7
A Plasma Pyrophosphate Cutoff Value for Diagnosing Pseudoxanthoma Elasticum.
Rubera I, Clotaire L, Laurain A, et al.
International journal of molecular sciences 2024; (25(12)) doi:10.3390/ijms25126502.
PMID: 38928212 - 8
Pseudoxanthoma elasticum-like papillary dermal elastolysis: a case report and review of literature.
Panagou E, Ratynska M, Heelan K
International journal of dermatology 2019; (58(1)):93-97 doi:10.1111/ijd.14093.
PMID: 29907963 - 9
Pseudoxanthoma Elasticum-Like Papillary Dermal Elastolysis (PXE-PDE) in an Elderly Female: A Rare Diagnostic Entity.
Alshehri N, Alsergani R, Alqerafi A, et al.
Clinical, cosmetic and investigational dermatology 2025; (18()):2451-2455 doi:10.2147/CCID.S548675.
PMID: 41036178 - 10
ENPP1 variants in patients with GACI and PXE expand the clinical and genetic heterogeneity of heritable disorders of ectopic calcification.
Ralph D, Nitschke Y, Levine MA, et al.
PLoS genetics 2022; (18(4)):e1010192 doi:10.1371/journal.pgen.1010192.
PMID: 35482848 - 11
GGCX mutations in a patient with overlapping pseudoxanthoma elasticum/cutis laxa-like phenotype.
Li D, Ryu E, Saeidian AH, et al.
The British journal of dermatology 2021; (184(6)):1170-1174 doi:10.1111/bjd.19576.
PMID: 33000479
This page provides educational information about diagnosing Pseudoxanthoma Elasticum (PXE) and genetic testing. It does not replace professional medical advice from a genetic counselor or your healthcare team.
Get notified when new evidence is published on Inherited pseudoxanthoma elasticum.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.